Sherbrooke Park Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,690
Closed -$615K 259
2025
Q3
$615K Buy
+7,690
New +$656K 0.29% 116
2025
Q2
Sell
-8,855
Closed -$830K 550
2025
Q1
$830K Sell
8,855
-92
-1% -$8.24K 0.39% 49
2024
Q4
$813K Sell
8,947
-2,081
-19% -$199K 0.26% 94
2024
Q3
$1.14M Buy
+11,028
New +$1.12M 0.26% 61
2024
Q2
Sell
-2,615
Closed -$235K 943
2024
Q1
$235K Buy
+2,615
New +$222K 0.05% 662
2023
Q4
Sell
-10,724
Closed -$763K 486
2023
Q3
$763K Sell
10,724
-11,113
-51% -$831K 0.24% 156
2023
Q2
$1.68M Buy
+21,837
New +$1.69M 0.88% 4

Other funds holding CL

Sherbrooke Park Advisers's CL Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 7,690 shares — an estimated $615K sold.

Sherbrooke Park Advisers first reported a position in CL in Q2 2023 and held it in 7 quarters. The position peaked at $1.68M in Q2 2023. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 7,690 Colgate-Palmolive shares in Q4 2025, an estimated $615K.
  • Sherbrooke Park Advisers first reported a position in Colgate-Palmolive in Q2 2023 and held it in 7 quarters.
  • Sherbrooke Park Advisers's Colgate-Palmolive position peaked at $1.68M in Q2 2023.
  • 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.